Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of June 6 to June 10, 2016.
GI & Endoscopy
In 2014, the average national rate of patients receiving appropriate follow-up interval for normal colonoscopy in average risk patients was 78.38, according to CMS' 2014 Ambulatory Surgical Center Quality Reporting Program results.
Valeant Pharmaceuticals is paying $54 million to settle kickback charges against its Salix unit, according to a Reuters report.
A study presented at the American Diabetes Association 2016 Scientific Sessions in New Orleans showed promising results in diabetic patients who underwent endoscopic duodenal mucosal resurfacing, also known as the Revita procedure, according to Medscape.
Jeffrey S. Crippin, MD, is the Marilyn E. Bornefield Chair in Gastrointestinal Research and Treatment at Washington University School of Medicine in St. Louis. He also serves as medical director of liver transplantation at Washington University School of Medicine.
Themistocles Dassopoulos, MD, is medical director of the Inflammatory Bowel Disease Center at Baylor University Medical Center in Dallas.
Here are eight gastroenterologists who recently made headlines.
Atlanta Gastroenterology Associates added Nader Dbouk, MD, according to a Rockdale Citizen report.
Steven H. Itzkowitz, MD, is a gastroenterologist at the Icahn School of Medicine at Mount Sinai in New York City. He previously served as chair of the gastrointestinal oncology section of the American Gastroenterological Association as well as co-chair of…
A study published in Clinical Therapeutics found potential cost savings associated with the use of the IBS diagnostic blood panel IBSchek.
